Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116268663 | 11626866 | 3 | F | 20160714 | 20151013 | 20160719 | EXP | US-PFIZER INC-2015339574 | PFIZER | 76.00 | YR | F | Y | 91.00000 | KG | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116268663 | 11626866 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY (EVERY MORNING) | 20753 | 25 | MG | COATED TABLET | QD | ||||||
| 116268663 | 11626866 | 2 | SS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, ALTERNATE DAY | 20753 | 25 | MG | COATED TABLET | QOD | ||||||
| 116268663 | 11626866 | 3 | SS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY (EVERY MORNING) | 20753 | 25 | MG | COATED TABLET | QD | ||||||
| 116268663 | 11626866 | 4 | C | LEVOTHYROXIN | LEVOTHYROXINE | 1 | Oral | 100 UG, 1X/DAY | 0 | 100 | UG | TABLET | QD | ||||||
| 116268663 | 11626866 | 5 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 120 MG, 1X/DAY | 0 | 120 | MG | TABLET | QD | ||||||
| 116268663 | 11626866 | 6 | C | HYDROCHLOROTH | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MG, 1X/DAY | 0 | 25 | MG | TABLET | QD | ||||||
| 116268663 | 11626866 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, 1X/DAY | 0 | 81 | MG | TABLET | QD | ||||||
| 116268663 | 11626866 | 8 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 1000 MG, 1X/DAY | 0 | 1000 | MG | TABLET | QD | ||||||
| 116268663 | 11626866 | 9 | C | VITAMIN A | VITAMIN A | 1 | Oral | 8000 IU, 1X/DAY | 0 | 8000 | IU | TABLET | QD | ||||||
| 116268663 | 11626866 | 10 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 400 IU, 1X/DAY | 0 | 400 | IU | CAPSULE | QD | ||||||
| 116268663 | 11626866 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | CAPSULE | |||||||||||
| 116268663 | 11626866 | 12 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, 1X/DAY | 0 | 75 | MG | TABLET | QD | ||||||
| 116268663 | 11626866 | 13 | C | POTASSIUM | POTASSIUM | 1 | Oral | 10 MEQ, 1X/DAY | 0 | 10 | MEQ | CAPSULE | QD | ||||||
| 116268663 | 11626866 | 14 | C | POTASSIUM | POTASSIUM | 1 | 0 | CAPSULE | |||||||||||
| 116268663 | 11626866 | 15 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 80 MG, 1X/DAY (1 AT NIGHT) | 0 | 80 | MG | TABLET | QD | ||||||
| 116268663 | 11626866 | 16 | C | TRAMADOL. | TRAMADOL | 1 | 50 MG, AS NEEDED (A HALF ONE EVERY 6 HOURS) | 0 | 50 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116268663 | 11626866 | 1 | Breast cancer |
| 116268663 | 11626866 | 4 | Thyroid disorder |
| 116268663 | 11626866 | 5 | Hypertension |
| 116268663 | 11626866 | 6 | Hypertension |
| 116268663 | 11626866 | 9 | Bone disorder |
| 116268663 | 11626866 | 10 | Bone disorder |
| 116268663 | 11626866 | 11 | Immune system disorder |
| 116268663 | 11626866 | 12 | Arterial disorder |
| 116268663 | 11626866 | 13 | Malaise |
| 116268663 | 11626866 | 14 | Hypokalaemia |
| 116268663 | 11626866 | 15 | Blood cholesterol increased |
| 116268663 | 11626866 | 16 | Pain in extremity |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116268663 | 11626866 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116268663 | 11626866 | Arterial thrombosis | |
| 116268663 | 11626866 | Cerebrovascular accident | |
| 116268663 | 11626866 | Dizziness | |
| 116268663 | 11626866 | Malaise | |
| 116268663 | 11626866 | Memory impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116268663 | 11626866 | 1 | 2012 | 0 | ||
| 116268663 | 11626866 | 2 | 2012 | 0 | ||
| 116268663 | 11626866 | 3 | 2012 | 0 | ||
| 116268663 | 11626866 | 8 | 2015 | 0 | ||
| 116268663 | 11626866 | 9 | 2015 | 0 | ||
| 116268663 | 11626866 | 10 | 2015 | 0 | ||
| 116268663 | 11626866 | 13 | 2015 | 0 | ||
| 116268663 | 11626866 | 15 | 2014 | 0 | ||
| 116268663 | 11626866 | 16 | 2015 | 0 |